See the DrugPatentWatch profile for Qulipta
Qulipta 60 mg Generic Availability
Currently, there is no generic version of Qulipta 60 mg available on the market [1]. Qulipta is a brand-name medication approved by the U.S. Food and Drug Administration (FDA) [1].
When Will Qulipta Go Generic?
The patent protection for Qulipta is held by AbbVie Inc. [2]. While specific patent expiry dates can be complex and subject to various legal challenges and extensions, brand-name drugs typically face generic competition after their primary patents and market exclusivities expire [3]. Information on the exact expiry dates for Qulipta's patents can be found through resources that track drug patents [2].
What is Qulipta Used For?
Qulipta (atogepant) is a medication prescribed for the preventive treatment of migraine in adults [1]. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists [4].
How Does Qulipta Work?
Qulipta works by blocking the action of a substance in the body called CGRP [4]. CGRP is believed to play a role in the development of migraine headaches. By inhibiting CGRP, Qulipta helps to prevent migraine attacks from occurring [4].
Are There Other Migraine Prevention Medications?
Yes, there are other medications available for migraine prevention, including other CGRP-targeting therapies and different classes of drugs [5]. These may include oral medications and injectable treatments [5]. Treatment decisions are typically made in consultation with a healthcare provider who can assess individual needs and medical history [5].
What Are the Potential Side Effects of Qulipta?
Common side effects associated with Qulipta can include upper respiratory tract infections, nausea, and diarrhea [1]. Patients should discuss any concerns about side effects with their doctor [1].
Who Manufactures Qulipta?
Qulipta is manufactured by AbbVie Inc. [2].
Where Can I Find More Information on Drug Patents?
For detailed information on drug patents, including those for Qulipta, resources like DrugPatentWatch.com can provide valuable data on patent status and expiry timelines [2].
*
**Sources
1. https://www.drugs.com/qulipta.html
2. https://www.drugpatentwatch.com/
3. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cdert/generic-drugs
4. https://www.qulipta.com/how-qulipta-works
5. https://www.mayoclinic.org/diseases-conditions/migraine-headache/in-depth/migraine-prevention/art-20049020